Bora CDMO Bora CDMO

X

Find Radio Compass News for Torezolid Phosphate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

https://www.globenewswire.com/news-release/2022/05/05/2436620/37424/en/Nabriva-Extends-Exclusive-Agreement-to-Promote-and-Distribute-SIVEXTRO-tedizolid-phosphate-in-the-U-S-Through-the-End-of-2026.html

GLOBENEWSWIRE
05 May 2022

https://finance.yahoo.com/news/nabriva-commences-exclusive-distribution-sivextro-161200366.html

YAHOO
15 Apr 2021

https://www.globenewswire.com/news-release/2020/07/15/2062852/0/en/Nabriva-Therapeutics-Enters-into-Exclusive-Agreement-to-Promote-and-Distribute-SIVEXTRO-tedizolid-phosphate-in-the-U-S.html#:~:text=Under%20the%20terms%20of%20the,with%20renewable%20three%2Dyear%20extensions.

GLOBENEWSWIRE
15 Jul 2020

http://www.prnewswire.com/news-releases/amplyx-pharmaceuticals-appoints-ciara-kennedy-phd-as-president-and-chief-executive-officer-300384074.html

PR NEWSWIRE
05 Jan 2017

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002846/WC500184804.pdf

Press Release EMA
31 Mar 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY